ReviewThe Journal of infectious diseases2021

Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review.

Sharana Mahomed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.